Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?

被引：0
作者：
Hachulla, E. [1 ]
机构：
[1] Hop Claude Huriez, Ctr Reference Malad Autoimmunes & Autoinflammatoi, Serv Med Interne & Immunol Clin, F-59037 Lille, France
来源：
REVUE DE MEDECINE INTERNE | 2019年 / 40卷 / 12期
关键词：
Nintedanib; Systemic sclerosis; Interstitial lung disease; SCLERODERMA LUNG; CONTROLLED-TRIAL; PLACEBO; CYCLOPHOSPHAMIDE;
D O I：
10.1016/j.revmed.2019.08.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 777
页数：3
相关论文
共 8 条
  • [1] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Distler, Oliver
    Highland, Kristin B.
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen D.
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Tetzlaff, Kay
    Kuwana, Masataka
    Maher, Toby M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26) : 2518 - 2528
  • [2] Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study
    Hachulla, E
    Gressin, V
    Guillevin, L
    Carpentier, P
    Diot, E
    Sibilia, J
    Kahan, A
    Cabane, J
    Francès, C
    Launay, D
    Mouthon, L
    Allanore, Y
    Tiev, KP
    Clerson, P
    de Groote, P
    Humbert, M
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 3792 - 3800
  • [3] SAFETY PROFILE OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    Highland, Kristin
    Distler, Oliver
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Kohlbrenner, Veronika
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Kuwana, Masataka
    Maher, Toby M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 200 - 200
  • [4] A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
    Hoyles, Rachel K.
    Ellis, Ross W.
    Wellsbury, Jessica
    Lees, Belinda
    Newlands, Pauline
    Goh, Nicole S. L.
    Roberts, Christopher
    Desai, Sujal
    Herrick, Ariane L.
    McHugh, Neil J.
    Foley, Noeleen M.
    Pearson, Stanley B.
    Emery, Paul
    Veale, Douglas J.
    Denton, Christopher P.
    Wells, Athol U.
    Black, Carol M.
    du Bois, Roland M.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 3962 - 3970
  • [5] PRESERVATION OF LUNG FUNCTION OBSERVED IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF TOCILIZUMAB FOR THE TREATMENT OF EARLY SSC
    Khanna, Dinesh
    Lin, Celia J. F.
    Goldin, Jonathan
    Kim, Grace
    Kuwana, Masataka
    Allanore, Yannick
    Batalov, Anastas
    Butrimiene, Irena
    Carreira, Patricia
    Matucci-Cerinic, Marco
    Distler, Oliver
    Kaliterna, Dusanka Martinovic
    Mihai, Carina
    Mogensen, Mette
    Olesinska, Marzena
    Pope, Janet
    Riemekasten, Gabriela
    Sofia Rodriguez-Reyne, Tatiana
    Santos, Maria Jose
    van Laar, Jacob M.
    Spotswood, Helen
    Siegel, Jeffrey
    Jahreis, Angelika
    Furst, Daniel
    Denton, Christopher
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 202 - 202
  • [6] Clinical Course of Lung Physiology in Patients With Scleroderma and Interstitial Lung Disease Analysis of the Scleroderma Lung Study Placebo Group
    Khanna, Dinesh
    Tseng, Chi-Hong
    Farmani, Niloofar
    Steen, Virginia
    Furst, Daniel E.
    Clements, Philip J.
    Roth, Michael D.
    Goldin, Jonathan
    Elashoff, Robert
    Seibold, James R.
    Saggar, Rajeev
    Tashkin, Donald P.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3078 - 3085
  • [7] The incidence of delirium after cardiac surgery in the elderly: protocol for a systematic review and meta-analysis
    Liao, Yulin
    Flaherty, Joseph H.
    Yue, Jirong
    Wang, Yanyan
    Deng, Chuanyao
    Chen, Ling
    [J]. BMJ OPEN, 2017, 7 (03):
  • [8] Cyclophosphamide versus placebo in scleroderma lung disease
    Tashkin, Donald P.
    Elashoff, Robert
    Clements, Philip J.
    Goldin, Jonathan
    Roth, Michael D.
    Furst, Daniel E.
    Arriola, Edgar
    Silver, Richard
    Strange, Charlie
    Bolster, Marcy
    Seibold, James R.
    Riley, David J.
    Hsu, Vivien M.
    Varga, John
    Schraufnagel, Dean E.
    Theodore, Arthur
    Simms, Robert
    Wise, Robert
    Wigley, Fredrick
    White, Barbara
    Steen, Virginia
    Read, Charles
    Mayes, Maureen
    Parsley, Ed
    Mubarak, Kamal
    Connolly, M. Kari
    Golden, Jeffrey
    Olman, Mitchell
    Fessler, Barri
    Rothfield, Naomi
    Metersky, Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (25) : 2655 - 2666
1